Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn's Disease: A Three-Patient Case Series.

Hanna LN, Quraishi B, Pelly T, Lung P, Tozer P, Hart A, Wong SY, Powell N

Open source

DOI
10.1093/ibd/izaf216
Published
2026 Jun 1
Container
Inflammatory bowel diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ibd/izaf216,
  title = {Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn's Disease: A Three-Patient Case Series.},
  author = {Hanna LN and Quraishi B and Pelly T and Lung P and Tozer P and Hart A and Wong SY and Powell N},
  year = {2026},
  journal = {Inflammatory bowel diseases},
  doi = {10.1093/ibd/izaf216},
  url = {https://doi.org/10.1093/ibd/izaf216}
}

RIS

TY  - JOUR
TI  - Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn's Disease: A Three-Patient Case Series.
AU  - Hanna LN
AU  - Quraishi B
AU  - Pelly T
AU  - Lung P
AU  - Tozer P
AU  - Hart A
AU  - Wong SY
AU  - Powell N
PY  - 2026
JO  - Inflammatory bowel diseases
DO  - 10.1093/ibd/izaf216
UR  - https://doi.org/10.1093/ibd/izaf216
ER  - 

APA

LN, H., B, Q., T, P., P, L., P, T., A, H., SY, W., & N, P. (2026). Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn's Disease: A Three-Patient Case Series.. Inflammatory bowel diseases. https://doi.org/10.1093/ibd/izaf216

Source records